Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis.
about
Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniaeBlockade of NMDA receptor subtype NR2B prevents seizures but not apoptosis of dentate gyrus neurons in bacterial meningitis in infant ratsGene expression in cortex and hippocampus during acute pneumococcal meningitisIncrease in hippocampal water diffusion and volume during experimental pneumococcal meningitis is aggravated by bacteremia.Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.The kynurenine pathway is involved in bacterial meningitis.Long-term effects from bacterial meningitis in childhood and adolescence on postural control.Vitamin B6 reduces hippocampal apoptosis in experimental pneumococcal meningitis.Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.Reprogramming the host response in bacterial meningitis: how best to improve outcome?A putative role for homocysteine in the pathophysiology of acute bacterial meningitis in childrenDramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malariaSleep disorders are long-term sequelae of both bacterial and viral meningitis.Review: apoptotic mechanisms in bacterial infections of the central nervous system.Attenuation of the bacterial load in blood by pretreatment with granulocyte-colony-stimulating factor protects rats from fatal outcome and brain damage during Streptococcus pneumoniae meningitis.The meningococcal ABC-Type L-glutamate transporter GltT is necessary for the development of experimental meningitis in miceReactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci.Emerging drugs for acute bacterial meningitis.Chemical sensing of neurotransmitters.Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from experimental studies.Brain-derived neurotrophic factor reduces inflammation and hippocampal apoptosis in experimental Streptococcus pneumoniae meningitis.Pretreatment with granulocyte colony-stimulating factor attenuates the inflammatory response but not the bacterial load in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits.Neurotoxicity of glia activated by gram-positive bacterial products depends on nitric oxide production.Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone.Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.Experimental pneumococcal meningitis: impaired clearance of bacteria from the blood due to increased apoptosis in the spleen in Bcl-2-deficient mice.Endolymphatic sac involvement in bacterial meningitis.Inhibition of the kynurenine-NAD+ pathway leads to energy failure and exacerbates apoptosis in pneumococcal meningitis.Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats.Regional differences in glutamine synthetase inhibition by L-methionine sulfoximine: a microdialysis study in the rabbit brain.Induction of the kynurenine pathway by neurotropic influenza A virus infection.Tissue distribution of indoleamine 2,3-dioxygenase in normal and malaria-infected tissue.The inflammatory response and neuronal injury in Streptococcus suis meningitis.
P2860
Q24548716-984188E3-44AB-4079-A996-E396B4133A29Q24803483-7F85D00D-096E-4F47-83C0-8274B21AA8B6Q30817171-1E57F19E-EE67-46C2-B2A8-D0C87D5E8967Q30828237-8CCCAFBC-1A25-4D51-9AC2-374BED91A3ECQ34003220-2160B63A-78A6-48D4-934D-10557B77B739Q34306405-E77908D5-8559-45F7-84CA-1FE591CC1AD5Q34535354-B32F70C3-DFB3-4C82-A78D-B5BFAEF7899DQ34974364-664DE3D3-A66D-41BE-86DB-D3E3B1FE435DQ34989271-F416F4BA-5714-44CA-A5A0-C8F875DBBA09Q35176266-4F959607-6F1B-4DFE-A644-F052533EE6E4Q35493302-D64B4246-28C0-43D4-BE25-65B916EB39BEQ35763798-104A0353-0CB5-48E2-A053-9E8E033F935BQ36142281-1CAF605B-443F-466E-B7D7-C04427E4A9B0Q36296389-C3A525A8-F732-42FE-94AB-4C526B6C9EF0Q36444863-A9BEAB58-330D-4A62-864D-DB1272E264D5Q37333380-3B0C3FB5-4B21-4384-A5D3-2023920AF949Q37361937-95813ED5-9A4E-4351-9EFC-2F464DAF43B8Q37558543-5FECF605-08FF-433B-AE0D-0BA18DE52AFDQ38204898-73BBCEC6-6546-4354-BF4C-BEE675CE0CEAQ38539643-D55C7B79-B1FC-4DFB-9148-7FD917B2F51BQ38640314-39F43659-9B0F-4F09-BD6E-C116B51178E2Q39613006-0B821209-D695-4954-B696-9647D3B37945Q39825685-0D23684B-DB49-421E-9574-DA46022F63BAQ40483584-9AF236A1-4D90-4A22-B026-CB53F8A6D1D3Q40558851-C2A2FF57-412B-4F5F-9C07-885F399C38B4Q40882957-B3A5EF8C-674B-425A-9D3C-64C728A1C9CAQ42231822-DBE52D89-DD7A-427F-8123-15CA95D269BEQ42860959-331397A2-800C-412C-8F0D-D385F9B58293Q43802111-F02A0BC9-0DA3-48D0-A70F-B3CDDBBFF238Q44386014-6DEC36A6-1F2C-41A5-8BBE-081EE5568710Q45392602-8DA9D335-F01B-417D-9751-0F1C658EE243Q47869902-592EC30A-D2ED-4123-9F70-82B57FCC4069Q55517984-7E8FB247-363B-4760-8A67-D5D9FD66F5E1
P2860
Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Neuroprotective effect of exci ...... rimental bacterial meningitis.
@en
Neuroprotective effect of exci ...... rimental bacterial meningitis.
@nl
type
label
Neuroprotective effect of exci ...... rimental bacterial meningitis.
@en
Neuroprotective effect of exci ...... rimental bacterial meningitis.
@nl
prefLabel
Neuroprotective effect of exci ...... rimental bacterial meningitis.
@en
Neuroprotective effect of exci ...... rimental bacterial meningitis.
@nl
P2093
P356
P1476
Neuroprotective effect of exci ...... rimental bacterial meningitis.
@en
P2093
P304
P356
10.1093/INFDIS/173.1.166
P407
P577
1996-01-01T00:00:00Z